Janney Montgomery Scott’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-68,068
| Closed | -$1.26M | – | 2799 |
|
|
2023
Q3 | $1.26M | Buy |
+68,068
| New | +$770K | ﹤0.01% | 1219 |
|
|
2020
Q3 | – | Sell |
-7,475
| Closed | -$358K | – | 2153 |
|
|
2020
Q2 | $358K | Buy |
7,475
+243
| +3% | +$18.8K | ﹤0.01% | 1531 |
|
|
2020
Q1 | $455K | Buy |
7,232
+555
| +8% | +$49.9K | ﹤0.01% | 1268 |
|
|
2019
Q4 | $827K | Sell |
6,677
-890
| -12% | -$79.7K | 0.01% | 1177 |
|
|
2019
Q3 | $502K | Sell |
7,567
-290
| -4% | -$19.5K | ﹤0.01% | 1389 |
|
|
2019
Q2 | $625K | Sell |
7,857
-1,080
| -12% | -$96.7K | ﹤0.01% | 1297 |
|
|
2019
Q1 | $1M | Buy |
8,937
+475
| +6% | +$51.9K | 0.01% | 1025 |
|
|
2018
Q4 | $853K | Sell |
8,462
-205
| -2% | -$21.2K | 0.01% | 1012 |
|
|
2018
Q3 | $1.09M | Buy |
8,667
+245
| +3% | +$25.9K | 0.01% | 975 |
|
|
2018
Q2 | $707K | Buy |
8,422
+1,285
| +18% | +$94.1K | 0.01% | 1191 |
|
|
2018
Q1 | $439K | Buy |
7,137
+700
| +11% | +$42.2K | ﹤0.01% | 1393 |
|
|
2017
Q4 | $376K | Buy |
6,437
+2,928
| +83% | +$185K | ﹤0.01% | 1472 |
|
|
2017
Q3 | $204K | Buy |
3,509
+74
| +2% | +$7.97K | ﹤0.01% | 1698 |
|
|
2017
Q2 | $416K | Buy |
3,435
+62
| +2% | +$7.18K | 0.01% | 1275 |
|
|
2017
Q1 | $381K | Sell |
3,373
-87
| -3% | -$10.2K | 0.01% | 1296 |
|
|
2016
Q4 | $376K | Sell |
3,460
-190
| -5% | -$22.6K | 0.01% | 1200 |
|
|
2016
Q3 | $601K | Buy |
+3,650
| New | +$575K | 0.01% | 874 |
|
|
2016
Q2 | – | Sell |
-3,698
| Closed | -$475K | – | 1217 |
|
|
2016
Q1 | $475K | Buy |
3,698
+467
| +14% | +$55.1K | 0.01% | 798 |
|
|
2015
Q4 | $483K | Sell |
3,231
-390
| -11% | -$66K | 0.01% | 827 |
|
|
2015
Q3 | $601K | Buy |
3,621
+391
| +12% | +$86K | 0.02% | 742 |
|
|
2015
Q2 | $780K | Buy |
3,230
+805
| +33% | +$214K | 0.02% | 918 |
|
|
2015
Q1 | $684K | Buy |
2,425
+785
| +48% | +$170K | 0.01% | 1118 |
|
|
2014
Q4 | $256K | Sell |
1,640
-960
| -37% | -$177K | 0.01% | 1802 |
|
|
2014
Q3 | $615K | Buy |
2,600
+1,550
| +148% | +$395K | 0.01% | 1125 |
|
|
2014
Q2 | $248K | Buy |
+1,050
| New | +$277K | 0.01% | 1775 |
|
Janney Montgomery Scott's ICPT Position: Q4 2023 in Review
Janney Montgomery Scott sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 68,068 shares — an estimated $1.26M sold.
Janney Montgomery Scott first reported a position in ICPT in Q2 2014 and held it in 25 quarters. The position peaked at $1.26M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Janney Montgomery Scott reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Janney Montgomery Scott sold 68,068 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $1.26M.
- Janney Montgomery Scott first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 25 quarters.
- Janney Montgomery Scott's Intercept Pharmaceuticals, Inc. position peaked at $1.26M in Q3 2023.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Janney Montgomery Scott's 13F filing for Q4 2023, filed 8 Feb 2024.